Gary W. Pace, Director at Pacira BioSciences, Inc. (PCRX), sold 60,000 shares at $66.83 ($4.0M) on 2022-02-28, disclosed to the SEC on 2022-03-01.
Open-market sale of $4.0M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.83 | 28,641 | $1.9M | 47.7% |
| 2 | $66.83 | 28,641 | $1.9M | 47.7% |
| 3 | $67.75 | 1,359 | $92K | 2.3% |
| 4 | $67.75 | 1,359 | $92K | 2.3% |
| Total | $66.87 avg | 60,000 | $4.0M | 100% |
| Filing → |
| CRDF | BUY | 2025-07-31 | $711K | — | Filing → |
| CRDF | BUY | 2024-12-12 | $940K | — | Filing → |
| PCRX | SELL | 2024-03-08 | $4.5M | — | Filing → |